Münchmeyer Petersen Capital Markets
Legal disclosures
Mandatory disclosures for investment research by Münchmeyer Petersen Capital Markets under MAR, MiFID II and Section 85 WpHG.
Last updated: 17/11/2026
Issuers
Each issuer page lists its company-specific conflicts of interest and recommendation history.
- 1&1 AG
- 2G Energy AG
- 7C Solarparken AG
- adesso SE
- Adidas AG
- ADTRAN Holdings Inc.
- AIXTRON SE
- Allane SE
- Allgeier SE
- Alzchem Group AG
- AMG Critical Materials N.V.
- Aroundtown SA
- ATOSS Software SE
- AUMOVIO SE
- Aurubis AG
- BASF SE
- Basler AG
- Bastei Lübbe AG
- Bayerische Motoren Werke AG
- BayWa AG
- Bechtle AG
- Beiersdorf AG
- Bertrandt AG
- Blue Cap AG
- BRAIN Biotech AG
- BRANICKS Group AG
- Brenntag SE
- Brockhaus Technologies AG
- CANCOM SE
- Ceconomy AG
- CENIT AG
- CEWE Stiftung & Co. KGaA
- Cherry SE
- Clearvise AG
- Commerzbank AG
- Continental AG
- Daimler Truck Holding AG
- Data Modul AG
- DATAGROUP SE
- DEFAMA Deutsche Fachmarkt AG
- Dermapharm Holding SE
- Deutsche Bank AG
- Deutsche Beteiligungs AG
- Deutsche Börse AG
- Deutsche EuroShop SE
- Deutsche Konsum Real Estate AG
- Deutsche Pfandbriefbank AG
- Deutsche Wohnen SE
- Deutz AG
- DHL AG
- Drägerwerk AG
- Dürr AG
- EDAG Engineering Group AG
- Einhell Germany AG
- Eleving Group S.A.
- ELMOS Semiconductor AG
- ElringKlinger AG
- Encavis AG
- Energiekontor AG
- Evonik Industries AG
- EVOTEC SE
- Exasol AG
- Fabasoft AG
- Fielmann Group AG
- flatexDEGIRO SE
- Formycon AG
- Fraport AG
- freenet AG
- FUCHS SE
- GEA Group AG
- Gerresheimer AG
- GFT Technologies SE
- Grammer AG
- GRENKE AG
- Hamborner REIT AG
- Hawesko Holding
- Heidelberger Druck AG
- Heliad AG
- HELLA GmbH & Co. KGaA
- HelloFresh SE
- Henkel AG
- HENSOLDT AG
- HMS Bergbau AG
- Hoenle AG
- Hornbach Holding AG & Co. KGaA
- Hugo Boss AG
- Hypoport SE
- INDUS Holding
- Infineon Technologies AG
- init innovation in traffic systems SE
- innoscripta SE
- Instone Real Estate Group SE
- Jenoptik AG
- JOST Werke SE
- Jungheinrich AG
- K+S AG
- KION GROUP AG
- Knorr-Bremse AG
- Koenig & Bauer AG
- Kontron AG
- Krones AG
- KSB SE & Co. KGaA
- KWS SAAT AG
- Lanxess AG
- LEG Immobilien AG
- Leifheit AG
- LPKF Laser & Electronics SE
- MAX Automation SE
- Medios AG
- Mercedes-Benz Group AG
- Meta Wolf AG
- MHP Hotel AG
- MPC Münchmeyer Petersen Capital AG
- MTU Aero Engines AG
- Multitude AG
- Mutares SE & Co. KGaA
- Nagarro SE
- Nemetschek AG
- net digital AG
- Netfonds AG
- NEXUS AG
- Nordex SE
- NORMA Group SE
- PATRIZIA SE
- Peach Property Group AG
- pferdewetten.de AG
- PNE AG
- POLYTEC Holding AG
- PORR AG
- Porsche AG
- Porsche Automobil Holding SE
- ProCredit Holding AG
- ProSiebenSat.1 Media SE
- Puma SE
- Pyrum Innovations AG
- q.beyond AG
- Rational AG
- Redcare Pharmacy N.V.
- RENK Group AG
- Rheinmetall AG
- Rosenbauer International AG
- RTL Group S.A.
- SAF-Holland SE
- SAP SE
- Sartorius AG
- Schaeffler AG
- Scout24 AG
- secunet Security Networks AG
- Semperit AG Holding
- SFC Energy AG
- Singulus Technologies AG
- Sino AG
- Sixt SE
- Sixt SE Pref.
- Smartbroker Holding AG
- SNP Schneider-Neureither & Partner SE
- Softing AG
- Stabilus SE
- STEICO SE
- STRATEC SE
- Ströer SE & Co. KGaA
- Südzucker AG
- SUSS MicroTec SE
- Symrise AG
- TAG Immobilien AG
- Takkt AG
- TeamViewer AG
- technotrans SE
- Telefónica Deutschland Holding AG
- The Naga Group AG
- TKMS AG & Co KGaA
- TRATON SE
- UBM Development AG
- UmweltBank AG
- United Internet AG
- Uzin Utz SE
- Verve Group SE
- Vivoryon Therapeutics N.V.
- Volkswagen AG
- Vonovia SE
- Vossloh AG
- Wacker Chemie AG
- Wacker Neuson SE
- WashTec
- Zalando SE
- ZEAL Network SE
No issuer matches your search.
Legal disclosures
Legal Disclaimer
This research report (“investment recommendation”) was prepared and passed on by Münchmeyer Petersen Capital Markets GmbH (“MPCM”). MPCM is majority-owned by MPC Münchmeyer Petersen & Co. GmbH. This research report is intended solely for the recipient and may not be passed on to another company without the prior consent of MPCM, regardless of whether the company is part of the same group or not. It contains selected information and does not purport to be complete. The investment recommendation is based on publicly available information and data ("information") believed to be reliable. MPCM accepts no liability for the accuracy, completeness or timeliness of the information or for losses arising from the use of this research report, except in cases of intent or gross negligence or injury to life, body or health. The foregoing limitations of liability also apply in favour of the legal representatives, employees and vicarious agents of MPCM. The investment recommendation constitutes neither an offer nor a solicitation of an offer for the purchase or sale of any security. It is possible that shareholders, management or employees of MPCM or its affiliated companies serve in a position of responsibility, e.g. as a member of the supervisory board, in the companies mentioned in the analysis. The opinions contained in this investment recommendation are subject to change without notice. The views expressed in this research report accurately reflect the research analyst’s personal views about the subject securities and issuers. Unless otherwise specified in the research report, no part of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views contained in the research report.
AI tools were used in the preparation of this investment recommendation. The entire content of the investment recommendation was reviewed by the analysts named in the respective contributions and published under their editorial responsibility.
Additional information for clients in the United States
1. This research report (the “Report”) is a product of MPCM, Germany. MPCM is the employer of the respective research analyst who has prepared the Report. The research analyst resides outside the United States and is not an associated person of any U.S. regulated broker-dealer and therefore is not subject to the supervision of any U.S. regulated broker-dealer.
2. For distribution in the United States, this Report is directed solely to “Major U.S. Institutional Investors” as described in Rule 15a-6 under the U.S. Securities Exchange Act of 1934.
3. Crédit Industriel et Commercial (CIC) and MPCM have concluded a Research Distribution Agreement that gives CIC Market Solutions Inc. exclusive distribution in France, the US and Canada of the MPCM research product.
4. The research reports are distributed in the United States of America by CIC pursuant to a SEC Rule 15a-6 agreement with CIC Market Solutions Inc. (CICI), a U.S. registered broker-dealer and an affiliated company of CIC, and are distributed solely to persons who qualify as “Major U.S. Institutional Investors” as defined in SEC Rule 15a-6 under the Securities Exchange Act of 1934.
5. Any person who is not a Major U.S. Institutional Investor must not rely on this communication. The delivery of this research report to any person in the United States of America is not a recommendation to effect any transactions in the securities discussed herein, or an endorsement of any opinion expressed herein.
Additional information for clients in the United Kingdom
This research report is directed only at persons in the United Kingdom who are professional clients or eligible counterparties for the purposes of the UK financial promotion and investment research regime. Persons who do not meet these criteria should not rely on this communication or act upon it.
Disclosure according to §85 of the German Securities Trading Act (WpHG), Art. 20 MAR incl. Commission Delegated Regulations (EU) 2016/958 and (EU) 2017/565
The valuation underlying the investment recommendation for the company analysed here is based on generally accepted and widely used methods of fundamental analysis, such as e.g. DCF model, Free Cash Flow Value Potential, NAV, peer group comparison or sum-of-the-parts model.
Valuation methods
The fair value / price target of a share is determined primarily using a discounted cash flow approach (DCF approach). The DCF-based valuation may be supplemented by other valuation methods such as a peer group comparison or a sum-of-the-parts model. Where appropriate (e.g. for banks, real estate companies), other methods such as a regression model are also used as the main valuation model.
DCF: The DCF model uses forecasts of future free cash flow, which are discounted within the WACC model at the weighted average cost of capital in order to determine their present value. As a rule, the weighted average cost of capital is used as the discount rate in order to reflect the time value of money, the risks of the cash flows and the financing structure of the company. The enterprise value is derived by means of the DCF analysis. The equity value is obtained by subtracting (adding) net debt (net cash).
FCF Value: The MPCM valuation method "FCF Value Potential" reflects the company’s ability to generate sustainable free cash flows. It is based on the "FCF Value Potential" – an FCF figure excluding growth. An indication of value is determined via the perpetuity of the "FCF Potential" of the respective year, taking into account the weighted cost of capital. The various value indications of the individual years add a time element to the DCF model (our preferred valuation model).
Peer group: The peer group comparison is a relative valuation approach and is used to derive the enterprise value. The peer group generally consists of sufficiently comparable listed companies, but the transaction values of unlisted companies may also be used for a comparison. A peer group comparison may be based on sales, earnings (e.g. EBITDA, EBIT, EPS) or other (e.g. free cash flow, book value, customers) metrics.
Sum-of-the-parts: A sum-of-the-parts valuation derives the enterprise value from the sum of the values of the individual assets. Various valuation methods are used here as required. The equity value is determined by deducting net debt.
Valuation methods for banks
The fair value / price target of a share is determined primarily using our regression model (P/BV / RoE). This model may be supplemented by other valuation methods such as a peer group comparison or a sum-of-the-parts model.
Regression model: In order to determine the fair value of a bank, we estimate the bank’s book value and its profitability on the basis of return on equity. The derived P/BV and the derived return on equity are compared with existing peers in a regression model in order to determine a fair value.
In individual cases, other valuation methods not listed here may also be applied; these are explained in the respective investment recommendation.
Prices
All prices of financial instruments given in an investment recommendation are the closing prices of the stock-market trading day preceding the respective publication date stated, unless another point in time is explicitly stated.
Analyst assessment, updates
The result of this fundamental valuation is modified to take into consideration the analyst’s assessment as regards the expected development of investor sentiment and its impact on the share price.
An investment recommendation reflects the opinion of the respective author at the point in time of its compilation. A change in the fundamental factors underlying the valuation can mean that the valuation is subsequently no longer accurate. Whether, or in what time frame, an update of this document follows has not been determined in advance.
The analysts of MPCM do not receive any remuneration – directly or indirectly – from investment banking activities of MPCM, MPC Münchmeyer Petersen & Co. GmbH or affiliated companies.
Possible deviations/ risks
Independent of the applied valuation method, there is the risk that the price target will not be met, for instance because of unforeseen changes in demand for the company’s products, changes in management, technology, economic development, interest rate development, operating and/or material costs, competitive pressure, supervisory law, exchange rate, taxation etc. For investments in foreign markets and instruments there are further risks, for instance based on exchange rate changes or changes in political and social conditions. Further information on the impact of changes in key valuation parameters on the price target ("sensitivity analysis") can be found in the respective investment recommendation in the valuation models presented, in the illustrations labelled "Sensitivity".
Additional internal and organisational arrangements to prevent or to deal with conflicts of interest have been implemented. Among these are the spatial separation of the analysts from the other employees of MPCM and the creation of areas of confidentiality. This prevents the exchange of information which could form the basis of conflicts of interest for MPCM in terms of the analysed issuer or its financial instruments.
Sources
Unless otherwise stated, all price-relevant data and consensus estimates have been obtained from FactSet.
Investment Recommendation
Investment recommendation: expected development of the price of the financial instrument up to the given price target, in the opinion of the analyst who covers this financial instrument. For possible conflicts of interest, see the next section.
-B-
Buy:
The price of the analysed financial instrument is expected to rise over the next 12 months.
-H-
Hold:
The price of the analysed financial instrument is expected to remain largely stable over the next 12 months.
-S-
Sell:
The price of the analysed financial instrument is expected to fall over the next 12 months.
“-“
Rating suspended:
The available information currently does not permit an evaluation of the company.
“-“
Discontinued:
Coverage of the analysed financial instrument has been discontinued. No investment recommendation or price target is maintained any longer.
REFERENCE IN ACCORDANCE WITH SECTION 85 OF THE GERMAN SECURITIES TRADING ACT (WPHG) AND ART. 20 MAR REGARDING POSSIBLE CONFLICTS OF INTEREST WITH REGARD TO ANALYSED COMPANIES:
The following conflicts of interest may arise in the preparation of an investment recommendation; the conflicts of interest existing for a specific investment recommendation are indicated in the respective investment recommendation with their number below the overview:
-1- MPCM or companies affiliated with it within the meaning of Section 271 (2) of the German Commercial Code (HGB) (“affiliated companies”), or an employee of these companies responsible for the compilation of the analysis, hold a share of more than 5% of the share capital of the analysed company.
-2- Within the previous twelve months, MPCM or affiliated companies participated in the management of a consortium for an issue in the course of a public offering of such financial instruments which are, or the issuer of which is, the subject of the investment recommendation.
-3- MPCM or affiliated companies manage financial instruments which are, or the issuers of which are, the subject of the investment recommendation, in a market by placing buy or sell orders.
-4- MPCM or an affiliated company has reached an agreement with the issuer to provide investment banking and/or investment services and the relevant agreement was in force in the previous 12 months or there arose for this period, based on the relevant agreement, the obligation to pay or to receive a service or compensation - provided that this disclosure does not result in the disclosure of confidential business information.
-5- MPCM or an affiliated company has reached an agreement with the analysed company on the compilation of the investment recommendation.
-6a- MPCM or affiliated companies hold a net long position of more than 0.5% of the total issued share capital of the analysed company.
-6b- MPCM or affiliated companies hold a net short position of more than 0.5% of the total issued share capital of the analysed company.
-6c- The issuer holds shares of more than 5% of the total issued capital of MPCM or of an affiliated company.
-7- MPCM, affiliated companies or an employee of these companies have other significant interests in relation to the analysed company, such as, for example, the exercising of mandates at the analysed company.
Copyright
Each investment recommendation, including all its parts, is protected by copyright. Any use beyond the limits of copyright law without consent is prohibited and punishable. This applies, in particular, to reproductions, translations, microfilming, and the storage and processing of the entire content or parts thereof in electronic media.